Gene W Park

US Patent:

D462150, Aug 27, 2002

Filed:

Apr 11, 2001

Appl. No.:

29/140103

Inventors:

James E. Rader - Pleasanton CA
Scott T. Haubrich - San Leandro CA
Richard Porticos - Los Altos CA
Gene Park - Oakland CA

Assignee:

The Clorox Company - Oakland CA

International Classification:

0402

US Classification:

D32 40

US Patent:

D486616, Feb 10, 2004

Filed:

Apr 11, 2001

Appl. No.:

29/140155

Inventors:

Michael J. Hall - South San Francisco CA
James E. Rader - Pleasanton CA
Robert W. Flagler - Pleasanton CA
Scott T. Haubrich - San Leandro CA
Karen S. Hefter - San Ramon CA
Richard Porticos - Los Altos CA
Gene Park - Oakland CA
Douglas Minkler - Livermore CA
David J. Sayler - Portland OR
Eric Y. Park - Portland OR

Assignee:

The Clorox Company - Oakland CA

International Classification:

0401

US Classification:

D32 45

US Patent:

D503253, Mar 22, 2005

Filed:

Jul 10, 2003

Appl. No.:

29/186188

Inventors:

James E. Rader - Pleasanton CA, US
Scott T. Haubrich - San Leandro CA, US
Richard Porticos - Los Altos CA, US
Gene Park - Oakland CA, US

Assignee:

The Clorox Company - Oakland CA

International Classification:

0401

US Classification:

D32 40

US Patent:

8017140, Sep 13, 2011

Filed:

May 21, 2007

Appl. No.:

11/804997

Inventors:

Syed Faiyaz Ahmed Hossainy - Fremont CA, US
Gordon Stewart - San Francisco CA, US
Deborah Kilpatrick - Los Altos CA, US
Jeffrey Ellis - San Francisco CA, US
Gene Park - Oakland CA, US
Gina Zhang - Fremont CA, US
Paul Consigny - San Jose CA, US
Yiwen Tang - San Jose CA, US

Assignee:

Advanced Cardiovascular System, Inc. - Santa Clara CA

International Classification:

A61F 13/00
A61F 2/00
A61K 9/14

US Classification:

424422, 424423, 424426, 424486

Abstract:

Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.

US Patent:

8435550, May 7, 2013

Filed:

Aug 13, 2008

Appl. No.:

12/191209

Inventors:

Jin Cheng - San Jose CA, US
Stephen Dugan - Berkeley CA, US
Gordon Stewart - San Francisco CA, US
Gina Zhang - Calabasas CA, US
Nancy Kirsten - Tucson AZ, US
Paul Consigny - San Jose CA, US
Christopher Feezor - San Jose CA, US
Gene Park - Santa Rosa CA, US
Wouter Roorda - Palo Alto CA, US
Syed F. A. Hossainy - Fremont CA, US

Assignee:

Abbot Cardiovascular Systems Inc. - Santa Clara CA

International Classification:

A61F 2/02

US Classification:

424423

Abstract:

A drug-delivery system is provided including at least 100 μg of everolimus and clobetasol, such that the ratio of everolimus to clobetasol is at least 10:1 (w/w) or the amount of everolimus by weight is at least 10 times more than clobetasol. The system can be a stent. Also provided a method of treating restenosis or vulnerable plaque of a blood vessel, the method includes locally administering to a patient a first drug selected from a group consisting of rapamycin (sirolimus), Biolimus A9, deforolimus, AP23572, tacrolimus, temsirolimus, pimecrolimus, zotarolimus (ABT-578), 40-O-(2-hydroxy)ethylrapamycin (everolimus), 40-O-(3-hydroxy)propylrapamycin, 40-O-[2-(2-hydroxy)ethoxy]ethylrapamycin, 40-O-tetrazolylrapamycin and 40-epi-(N1-tetrazolyl)rapamycin, and locally administering to a patient a second drug consisting of clobetasol, wherein the minimum amount of the first drug that is locally administered is 100 μg, and wherein the ratio of the first drug to the second drug is, for example, 10:1 to 100:1 (w/w).

US Patent:

8586069, Nov 19, 2013

Filed:

Dec 29, 2005

Appl. No.:

11/322282

Inventors:

Gordon Stewart - San Francisco CA, US
Gina Zhang - Fremont CA, US
Nancy Kirsten - San Carlos CA, US
Paul Consigny - San Jose CA, US
Stephen Dugan - San Francisco CA, US
Gene Park - Oakland CA, US
Christopher Feezor - San Jose CA, US
Wouter Roorda - Palo Alto CA, US
Syed Faiyaz Ahmed Hossainy - Fremont CA, US

Assignee:

Abbott Cardiovascular Systems Inc. - Santa Clara CA

International Classification:

A61F 13/00
A61F 2/00

US Classification:

424422, 424423

Abstract:

Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.

US Patent:

20030180083, Sep 25, 2003

Filed:

Jan 24, 2003

Appl. No.:

10/351293

Inventors:

Michael Hall - South San Francisco CA, US
James Rader - Pleasanton CA, US
Boli Zhou - Tualatin OR, US
Karen Hefter - San Ramon CA, US
David Sayler - Portland OR, US
Eric Park - Portland OR, US
Robert Flagler - Pleasanton CA, US
Scott Haubrich - San Leandro CA, US
Shumanta MItra - Dublin CA, US
Richard Porticos - Los Altos CA, US
Gene Park - Pleasanton CA, US

International Classification:

A46B011/00
A47L013/22

US Classification:

401/140000, 401/270000, 401/278000, 401/138000

Abstract:

A cleaning pad for use on a cleaning system in which cleaning fluid or other liquid is dispensed onto a surface in front of a cleaning head portion, the cleaning pad comprising a central absorbent and scrubbing portion, a back edge portion for removably attaching the cleaning pad to the cleaning head portion, and a front edge portion for removably attaching the cleaning pad to the cleaning head portion, the front edge portion having a notch thereon, thereby allowing attachment of the cleaning pad to the cleaning head portion such that cleaning or other fluid can be dispensed from the cleaning head portion onto a surface in front of the cleaning head portion without interference by the cleaning pad.

US Patent:

20050287184, Dec 29, 2005

Filed:

Jun 29, 2004

Appl. No.:

10/881540

Inventors:

Syed Hossainy - Fremont CA, US
Gordon Stewart - San Francisco CA, US
Deborah Kilpatrick - Los Altos CA, US
Jeffrey Ellis - San Francisco CA, US
Gene Park - Oakland CA, US
Gina Zhang - Fremont CA, US
Paul Consigny - San Jose CA, US
Yiwen Tang - San Jose CA, US

International Classification:

A61K031/56
A61K031/4745

US Classification:

424423000, 514171000, 514291000

Abstract:

Drug-delivery stents capable of providing release of two or more drugs such as everolimus and estradiol are provided. The stents can be used for treating a disease such as restenosis and vulnerable plaque.